Liposome manufacturing market Analysis: Emerging Growth Drivers, Strategic Trends & Key Segments Forecast to 2035
Liposomes are small, artificial and lipid-based bilayered spherical vesicles, which are created spontaneously by hydrated phospholipids.
The global liposome manufacturing market is likely to grow from USD 0.9 bn in 2025 to USD 1.0 bn in 2026 and USD 2.3 bn by 2035, representing a CAGR of 10.1%c during the forecast period.
Liposomes are artificial vesicles that carry the potential to be used as an effective drug delivery and model membrane system. During our research, we identified 72 players that provide services for the development and manufacturing of liposomes.
Majority of the players (33%) offering liposome development and manufacturing services were established post-2010. This is indicative of the growing interest of stakeholders in this domain. Examples of some recently established players, include (in reverse chronological order of year of establishment; established post-2017) Amerigo Scientific (202, DIANT Pharma (2019), GMPriority Pharma (2019), Supplement Manufacturing Partners (SMP Nutra) (2019), and S G Biopharm (2018). This is followed by 25% of the companies established between 2001-2010.
Further, the current market landscape is dominated by the presence of mid-sized companies (37%), which represent more than 35% of the total number of players in this domain. Notable examples of mid-sized players that provide services for liposome development and manufacturing, include (in alphabetical order, no selection criteria) Ardena, BJP Laboratories, Creative Biolabs, Eurofins Advinus, GP Pharm, and Polymun Scientific.
As is evident from the figure, 74% of the players offer services for liposome formulation development, followed by the players which offer analytical method development (65%) and contract manufacturing services (64%). Further, 61% of the companies provide services for the process development of liposomes. Examples of some companies offering formulation development, contract manufacturing, analytical method development and process development services for liposomes, include (in alphabetical order, no selection criteria) Althea, BSP Pharmaceuticals, Creative Biostructure, Exelead, GP Pharm, and Polymun Scientific.
Further, majority of the liposome development and manufacturing service providers (58%) use stability analysis method for the quantification of liposomes, followed by the players that employ encapsulation efficiency determination method (43%). It is worth highlighting that liposome stability during storage or processing in the human body are two key considerations in liposome design and application, when using liposomes as drug carriers. Examples of players employing stability analysis method for liposomes, include (in alphabetical order, no selection criteria) Amerigo Scientific, BOC Sciences, Empirial Labs, and Etico Lifesciences.
Presently, most of the liposome development and manufacturing service providers (68%) offer services for discovery / research purposes. Examples of such companies, include (in alphabetical order, no selection criteria) Ardena, Corden Pharma, Curia, and Esco Aster. This is followed by service providers (53% each) offering services across preclinical and clinical scale of operation. Notable examples of such companies, include (in alphabetical order, no selection criteria) Althea, Biofuture Medicine and GP Pharm. It is worth mentioning that companies namely, (in alphabetical order, no selection criteria) Avanti Polar Lipids, Charles River Laboratories and Piramal Pharma Solutions, offer services across all (discovery / research, preclinical, clinical, and commercial) scales of operation.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Liposome Manufacturing Market.
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/liposome-man
